Immunological response to tumor ischemia in a murine renal cell carcinoma model

Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli.

Journal of general microbiology·1992

The association of benign prostatic hyperplasia and cancer of the prostate.

Cancer·1992

Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Findings of the American Cancer Society National Prostate Cancer Detection Project.

Cancer·1992

The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography. Findings of the American Cancer Society National Prostate Cancer Detection Project.

Cancer·1992

Lucy Wortham James Basic Research Award. Markers of prostatic carcinoma.

Archives of surgery (Chicago, Ill. : 1960)·1991

The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men.

Cancer·1991

Glucose metabolism assessed by fluorodeoxyglucose positron emission tomography and response to chemoimmunotherapy in esophageal squamous cell carcinoma: An exploratory analysis.

Oncology·2026

Biomarker-Oriented Contextual Analysis of First-Line Zolbetuximab and Immunotherapy-Based Strategies in HER2-Negative Metastatic Gastric Cancer.

Oncology·2026

CCL5, CLEC11A, IL-7, IL-8, and IL-13: Diagnostic serum biomarkers of gastric cancer identified in a 48-multiplex panel.

Oncology·2026

Effects of amputation versus limb salvage surgery on the prognosis of primary extremity chondrosarcoma: Evidence from the Surveillance, Epidemiology, and End Results database.

Oncology·2026

Low Stromal CD11c Expression Indicates a Poor Prognosis in Rectal Cancer Patients.

Oncology·2026

Impact of Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil-Induced Neutropenia on Histological Tumor Response in Esophageal Squamous Cell Carcinoma: A Retrospective Study.

Oncology·2026

Co-occurrence of GATA2 deficiency and probable constitutional mosaic STAG2 alteration in a young adult with myelodysplastic syndrome: a case report.

Frontiers in medicine·2026

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Haematologica·2026

Venous Thromboembolism in Patients Treated with Everolimus: Insights from a Case Series and the French Pharmacovigilance Database.

Current vascular pharmacology·2026

Hepatocellular Carcinoma With JAK1 Mutations Harbors Distinct Histologic Features and Specific Mutational Hotspots in an Asian Cohort.

The American journal of surgical pathology·2026

TH/TRs-COL11A2 Axis Mediates Loss of a Differentiated Astrocyte State in Hypogyrified Brains.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Functional contribution of Epstein-Barr virus BARF1 residues 35-39 to viable cell maintenance under serum deprivation and tumor formation.

Virus genes·2026

Related Experiment Videos

Immunological response to tumor ischemia in a murine renal cell carcinoma model

Related Concept Videos

Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli.

The association of benign prostatic hyperplasia and cancer of the prostate.

Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Findings of the American Cancer Society National Prostate Cancer Detection Project.

The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography. Findings of the American Cancer Society National Prostate Cancer Detection Project.

Lucy Wortham James Basic Research Award. Markers of prostatic carcinoma.

The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men.

Glucose metabolism assessed by fluorodeoxyglucose positron emission tomography and response to chemoimmunotherapy in esophageal squamous cell carcinoma: An exploratory analysis.

Biomarker-Oriented Contextual Analysis of First-Line Zolbetuximab and Immunotherapy-Based Strategies in HER2-Negative Metastatic Gastric Cancer.

CCL5, CLEC11A, IL-7, IL-8, and IL-13: Diagnostic serum biomarkers of gastric cancer identified in a 48-multiplex panel.

Effects of amputation versus limb salvage surgery on the prognosis of primary extremity chondrosarcoma: Evidence from the Surveillance, Epidemiology, and End Results database.

Low Stromal CD11c Expression Indicates a Poor Prognosis in Rectal Cancer Patients.

Impact of Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil-Induced Neutropenia on Histological Tumor Response in Esophageal Squamous Cell Carcinoma: A Retrospective Study.

Co-occurrence of GATA2 deficiency and probable constitutional mosaic STAG2 alteration in a young adult with myelodysplastic syndrome: a case report.

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Venous Thromboembolism in Patients Treated with Everolimus: Insights from a Case Series and the French Pharmacovigilance Database.

Hepatocellular Carcinoma With JAK1 Mutations Harbors Distinct Histologic Features and Specific Mutational Hotspots in an Asian Cohort.

TH/TRs-COL11A2 Axis Mediates Loss of a Differentiated Astrocyte State in Hypogyrified Brains.

Functional contribution of Epstein-Barr virus BARF1 residues 35-39 to viable cell maintenance under serum deprivation and tumor formation.

Related Experiment Videos

Immunological response to tumor ischemia in a murine renal cell carcinoma model

Related Concept Videos

Related Articles